Terms: = Lung cancer AND TRD AND Treatment
9 results:
1. A randomized sham-controlled trial of high-dosage accelerated intermittent theta burst rTMS in major depression: study protocol.
Goodman MS; Vila-Rodriguez F; Barwick M; Burke MJ; Downar J; Hunter J; Kaster TS; Knyahnytska Y; Kurdyak P; Maunder R; Thorpe K; Trevizol AP; Voineskos D; Zhang W; Blumberger DM
BMC Psychiatry; 2024 Jan; 24(1):28. PubMed ID: 38191370
[TBL] [Abstract] [Full Text] [Related]
2. Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042).
Minegishi Y; Akagami T; Arai M; Saito R; Arai D; Murase K; Miura K; Watanabe S; Sakashita H; Miyabayashi T; Honda R; Jingu D; Hotta T; Isobe K; Nakazawa K; Ito K; Takamura K; Inomata M; Harada T; Sakakibara R; Nakagawa T; Shibuya H; Takenaka K; Kobayashi K; Seike M
Lung Cancer; 2022 Oct; 172():1-8. PubMed ID: 35952438
[TBL] [Abstract] [Full Text] [Related]
3. treatment-Related Death during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell lung cancer: A Meta-Analysis of Randomized Studies.
Zhao J; Xia Y; Kaminski J; Hao Z; Mott F; Campbell J; Sadek R; Kong FM
PLoS One; 2016; 11(6):e0157455. PubMed ID: 27300551
[TBL] [Abstract] [Full Text] [Related]
4. Risk of treatment related death and febrile neutropaenia with first line palliative chemotherapy for de novo metastatic breast cancer in clinical practice in a middle resource country.
Phua CE; Tang WH; Yusof MM; Saad M; Alip A; See MH; Taib NA
Asian Pac J Cancer Prev; 2014; 15(23):10263-6. PubMed ID: 25556458
[TBL] [Abstract] [Full Text] [Related]
5. treatment-related death in patients with small-cell lung cancer in phase III trials over the last two decades.
Ochi N; Hotta K; Takigawa N; Oze I; Fujiwara Y; Ichihara E; Hisamoto A; Tabata M; Tanimoto M; Kiura K
PLoS One; 2012; 7(8):e42798. PubMed ID: 22880112
[TBL] [Abstract] [Full Text] [Related]
6. Risk factors for treatment-related death associated with chemotherapy and thoracic radiotherapy for lung cancer.
Minami-Shimmyo Y; Ohe Y; Yamamoto S; Sumi M; Nokihara H; Horinouchi H; Yamamoto N; Sekine I; Kubota K; Tamura T
J Thorac Oncol; 2012 Jan; 7(1):177-82. PubMed ID: 22134071
[TBL] [Abstract] [Full Text] [Related]
7. Time trend in treatment-related deaths of patients with advanced non-small-cell lung cancer enrolled into phase III trials of systemic treatment.
Fujiwara Y; Hotta K; Di Maio M; Kiura K; Takigawa N; Tabata M; Tanimoto M
Ann Oncol; 2011 Feb; 22(2):376-82. PubMed ID: 20699278
[TBL] [Abstract] [Full Text] [Related]
8. treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy.
Song CH; Pyo H; Moon SH; Kim TH; Kim DW; Cho KH
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):651-8. PubMed ID: 20207499
[TBL] [Abstract] [Full Text] [Related]
9. Risk factors of treatment-related death in chemotherapy and thoracic radiotherapy for lung cancer.
Ohe Y; Yamamoto S; Suzuki K; Hojo F; Kakinuma R; Matsumoto T; Ohmatsu H; Nishiwaki Y
Eur J Cancer; 2001 Jan; 37(1):54-63. PubMed ID: 11165130
[TBL] [Abstract] [Full Text] [Related]
